Age at treatment predicts reason for discontinuation of TNF antagonists: data from the BIOBADASER 2.0 registry.

  1. Busquets, N.
  2. Tomero, E.
  3. Descalzo, M.A.
  4. Ponce, A.
  5. Ortiz-Santamaría, V.
  6. Surís, X.
  7. Carmona, L.
  8. Gómez-Reino, J.J.
  9. BIOBADASER 2.0 Study Group, null
Journal:
Rheumatology (Oxford, England)

ISSN: 1462-0332

Year of publication: 2011

Volume: 50

Issue: 11

Pages: 1999-2004

Type: Article

DOI: 10.1093/RHEUMATOLOGY/KER281 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus